Dermatology news

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Don't prescribe antibiotics for non-bullous impetigo, draft NICE guidance advises

Topical antiseptics are preferable to antibiotics for...

Bath emollients among further prescribing restrictions issued by NHS England

Bath emollients among further prescribing restrictions issued by NHS England

GPs should no longer routinely prescribe bath and shower...

Trimovate available to prescribe again

Trimovate available to prescribe again

GPs can prescribe the steroid/antibiotic cream Trimovate...

New pregnancy prevention measures for retinoid products

New pregnancy prevention measures for retinoid products

Further restrictions have been announced on the use...

Prescribing restrictions considered for diabetes and eczema products

Prescribing restrictions considered for diabetes and eczema products

Prescribing of blood glucose testing strips and bath...

Update on dermatological signs of child abuse with a free interactive learning module from MIMS Learning

Update on dermatological signs of child abuse with a free interactive learning module from MIMS Learning

MIMS Learning is offering an interactive module on...

Doctors identify 50 'unnecessary' medical interventions

Doctors identify 50 'unnecessary' medical interventions

A list of 50 tests, treatments and procedures 'of questionable...

NICE approves guselkumab for plaque psoriasis

NICE approves guselkumab for plaque psoriasis

Guselkumab (Tremfya) is now an option for routine NHS...

Emollient bath additives 'no benefit' in childhood eczema

Emollient bath additives 'no benefit' in childhood eczema

Emollient bath additives provide no clinical benefit...

Psoriasis biologic approved for NHS prescribing

Psoriasis biologic approved for NHS prescribing

Brodalumab (Kyntheum) can now be prescribed routinely...

Dupilumab: first biologic for moderate-to-severe atopic dermatitis

Dupilumab: first biologic for moderate-to-severe atopic dermatitis

Dupilumab (Dupixent) is the first biologic treatment...

Guselkumab further extends choice in psoriasis prescribing

Guselkumab further extends choice in psoriasis prescribing

Tremfya (guselkumab) is licensed for the treatment...

NICE approval for new psoriasis tablet

NICE approval for new psoriasis tablet

Dimethyl fumarate (Skilarence) is now an option for...

Topical psoriasis treatment to be available without a prescription

Topical psoriasis treatment to be available without a prescription

Patients with psoriasis will be able to buy Dovonex...

Fumaric acid ester now available as licensed oral psoriasis treatment

Fumaric acid ester now available as licensed oral psoriasis treatment

Prescribers treating patients with moderate to severe...

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Brodalumab: a new biologic for moderate-to-severe plaque psoriasis

Kyntheum (brodalumab) injection is now available for...

Cardiovascular warning for rosacea gel

Cardiovascular warning for rosacea gel

Patients using the topical rosacea treatment brimonidine...

NHS approval for latest psoriasis biologic

NHS approval for latest psoriasis biologic

NICE has recommended ixekizumab (Taltz) as an option...

Psychiatric advice issued for psoriasis treatment

Psychiatric advice issued for psoriasis treatment

The prescribing information for apremilast (Otezla)...